Jubilant Cadista Pharmaceuticals, Inc. is recalling approximately 635,400 cartons of Methylprednisolone Tablets USP (4 mg), a prescription medication used to treat inflammation. The recall was initiated because the dosing instructions on the blister card packaging are misaligned and illegible. This defect could cause a patient to take the wrong amount of medication, which may lead to inadequate treatment of their condition or potential side effects from incorrect dosing. These products were distributed nationwide across the United States and Puerto Rico.
The misaligned printing on the blister card makes the specific dosing instructions difficult or impossible to read. If a patient cannot follow the prescribed tapering schedule or daily dosage correctly, it could result in sub-therapeutic treatment of serious inflammatory conditions or accidental overdose.
Guidance and refund for unused medication.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.